Adropin and Irisin in Patients with Cardiac Cachexia
- PMID: 30110044
- PMCID: PMC6078362
- DOI: 10.5935/abc.20180109
Adropin and Irisin in Patients with Cardiac Cachexia
Figures
Comment on
-
Adropin and Irisin in Patients with Cardiac Cachexia.Arq Bras Cardiol. 2018 Jul;111(1):39-47. doi: 10.5935/abc.20180109. Epub 2018 Jul 2. Arq Bras Cardiol. 2018. PMID: 29972412 Free PMC article.
References
-
- Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med. 1964 Aug 20;271:403–409. - PubMed
-
- Velloso LG, Csengeri LF, Alonso RR, Ciscato CM, Barreto AC, Bellotti G, et al. Malnutrition in dilated cardiomyopathy. Correlation with echocardiographic indices of left ventricular function. Arq Bras Cardiol. 1992;58(3):189–192. - PubMed
-
- Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361(9363):1077–1083. - PubMed
-
- Veloso LG, de Oliveira MT, Jr, Munhoz RT, Morgado PC, Ramires JA, Barretto AC. Nutritional repercussion in advanced heart failure and its value in prognostic assessment. Arq Bras Cardiol. 2005;84(6):480–485. - PubMed
-
- Veloso LG, Pereira-Barretto AC, de Oliveira MT, Jr, Munhoz RT, Morgado PC, Ramires JA. Score for nutritional status evaluation: the role played in the prognostic stratification of dilated cardiomyopathy and advanced heart failure patients. Arq Bras Cardiol. 2006;87(2):178–184. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
